← Leaderboards
R Kent Hermsmeyer
Dimera, Inc.
$5,700,406
Attributed
$5,700,406
Total exposure
11
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–08$2M$1.5M$1M$500K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$5,700,406 · 11
By mechanism
R44$2,861,251 · 2
R01$1,530,750 · 1
P51$1,049,648 · 6
R43$258,757 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Macaca Mulatta”
- Barton F Haynes · Duke University$291,595,855
- Peter Gordon Gillespie · Oregon Health And Science University$83,402,374
- Richard A Gibbs · Baylor College Of Medicine$82,928,769
- Dan H. Barouch · Fred Hutchinson Cancer Center$67,567,747
- David I Watkins · George Washington University$57,087,952
- Rama Rao Amara · Emory University$54,145,017
Research focus
Macaca MulattaPostmenopauseCoronary ArteryClinical ResearchFemaleMammaliaWomen'S HealthProgesteroneImmunocytochemistryThromboxanesDrug Screening /EvaluationReceptor ExpressionHormone Regulation /Control MechanismTopical Drug ApplicationProtein Kinase CVasomotionEstrogensPathologic ProcessAngiographyCalcium FluxInstitutionBlood VesselsMenopauseGrant
Grant awards (19)
ER-BETA SELECTIVE AGONIST CORONARY PROTECTION IN MENOPAUSE$173,682
P51 · FY2008 · RR · contact PI
ER-BETA SELECTIVE AGONIST CORONARY PROTECTION IN MENOPAUSE$104,647
P51 · FY2007 · RR · contact PI
CORONARY REACTIVITY AND THROMBOXANE RECEPTOR EXPRESSION$104,647
P51 · FY2007 · RR · contact PI
ER beta selective agonist coronary protection-menopause$893,450
R44 · FY2005 · HL
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2005 · HL
ER beta selective agonist coronary protection-menopause$958,300
R44 · FY2004 · HL
Coronary Reactivity and Thromboxane Receptor Expression$353,250
R01 · FY2004 · HL
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2003 · HL
ER beta selective agonist coronary protection--menopause$133,757
R43 · FY2003 · HL
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2002 · HL
COMPARISON OF NOMEGESTROL ACETATE TO MEDROXYPROGESTERONE ACETATE$111,112
P51 · FY2002 · RR
PROTECTION AGAINST CORONARY HYPERREACTIVITY BY ESTROGENS &PROGESTINS$111,112
P51 · FY2002 · RR
ESTROGEN &PROGESTERONE ACTIONS ON VASCULAR MUSCLE CELLS$111,112
P51 · FY2002 · RR
ESTROGEN &PROGESTERONE ACTIONS ON VASCULAR MUSCLE CELLS$111,112
P51 · FY2001 · RR
COMPARISON OF NOMEGESTROL ACETATE TO MEDROXYPROGESTERONE ACETATE$111,112
P51 · FY2001 · RR
PROTECTION AGAINST CORONARY HYPERREACTIVITY BY ESTROGENS &PROGESTINS$111,112
P51 · FY2001 · RR
HORMONE REPLACEMENT THERAPY WITH PROGESTERONE CREAM$677,301
R44 · FY2000 · AG
HORMONE REPLACEMENT THERAPY WITH PROGESTERONE CREAM$332,200
R44 · FY2000 · AG
HORMONE REPLACEMENT THERAPY WITH ESTRIOL SKIN CREAM$125,000
R43 · FY2000 · AG